Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for ADC Therapeutics SA in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
RG
Redmile Group, LLC
|
11.5M | 7.42% | −3.9M (−25.5%) | ≤2021 | 0.8% | |
|
Shares held by quarter
Peak holding15.7M (Q3'24)
Change over 8 quarters−4.1M
Share of the company7.420%
|
||||||
|
NC
Nantahala Capital Management, LLC
|
12.3M | 7.93% | +6.7M (+120.2%) | 2025 | 0.4% | |
|
Shares held by quarter
Peak holding12.3M (Q2'26)
Change over 8 quarters+12.3M
Share of the company7.930%
|
||||||
28 more super investors behind a free account
See every manager holding ADC Therapeutics SA, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
EH
Mutual Fund Series Trust
|
$21.4M | 5.7M | 3.67% | 1.35% | March 31, 2026 |
|
VU
Vanguard Wellington Fund
|
$1.08M | 316.8K | 0.20% | 0.06% | May 31, 2026 |
23 more funds behind a free account
See every fund holding ADC Therapeutics SA and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
WH
Wild Hans Peter
Insider
|
9.8M | 6.30% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company6.300%
|
||||||
|
MA
Mallik Ameet
Insider
|
2.8M | 1.80% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company1.800%
|
||||||
12 more holders behind a free account
See every insider and 5%+ holder of ADC Therapeutics SA.
Sign up freeLoading...